JSPR - Jasper Therapeutics Inc
1.38
0.010 0.725%
Share volume: 1,174,074
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.37
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-07-2024 | 02-28-2025 | 05-12-2025 | 11-10-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 15.072 M | 15.993 M | 19.889 M | 25.285 M | 21.802 M | 19.166 M | |
| Selling general and admin | 4.774 M | 4.697 M | 5.434 M | 5.513 M | 5.645 M | 4.775 M | |
| Research and development | 10.298 M | 11.296 M | 14.455 M | 19.772 M | 16.157 M | 14.391 M | |
| Total expenses | 15.072 M | 15.993 M | 19.889 M | 25.285 M | 21.802 M | 19.166 M | |
| 6.11% | 24.36% | 27.13% | -13.77% | -12.09% | |||
| Operating income | -15.072 M | -15.993 M | -19.889 M | -25.285 M | -21.802 M | -19.166 M | |
| Ebit | -15.114 M | -16.033 M | -19.921 M | -25.259 M | -21.865 M | -19.078 M | |
| Pretax income | -13.728 M | -14.583 M | -18.637 M | -24.321 M | -21.241 M | -18.736 M | |
| 6.23% | 27.80% | 30.50% | -12.66% | -11.79% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -13.728 M | -14.583 M | -18.637 M | -24.321 M | -21.241 M | -18.736 M | |
| -6.23% | -27.80% | -30.50% | 12.66% | 11.79% |